H1B Salary Data

Home › Employers › Memorial Sloan Kettering Cancer Center › Computational Biologist I

Computational Biologist I at Memorial Sloan Kettering Cancer Center: H-1B salaries

14 labor condition applications for the job title Computational Biologist I at Memorial Sloan Kettering Cancer Center. Median offered base salary $99,000; middle half $90,250–$105,000.

Applications (LCAs)14
Median offered salary$99,000
Middle half of salaries$90,250–$105,000
10th–90th percentile$86,000–$114,100

By fiscal year

Fiscal yearLCAsMedian salary
FY20233$86,000
FY20244$99,000
FY20255$100,000
FY20262$93,500

Applications

Base salaryLocationSubmittedStart dateStatus
$105,000–$115,000
Level I		New York, NYApr 22, 2026Apr 22, 2026Certified
$82,000–$131,200
Level I		New York, NYApr 20, 2026Jul 17, 2026Certified
$90,000–$100,000
Level II		New York, NYMay 15, 2025Aug 1, 2025Certified
$115,000–$125,000
Level IV		New York, NYMar 14, 2025Apr 7, 2025Certified
$115,000–$125,000
Level IV		New York, NYFeb 26, 2025Mar 31, 2025Certified
$91,000–$101,000
Level II		New York, NYDec 11, 2024Dec 20, 2024Certified
$100,000–$110,000
Level II		New York, NYOct 23, 2024Jan 10, 2025Certified
$99,000–$109,000
Level II		New York, NYJul 15, 2024Aug 12, 2024Certified
$95,000–$105,000
Level II		New York, NYJul 15, 2024Aug 12, 2024Certified
$105,000–$115,000
Level III		New York, NYJun 13, 2024Jul 15, 2024Certified
$99,000–$109,000
Level III		New York, NYDec 13, 2023Feb 15, 2024Certified
$112,000
Level III		New York, NYMay 25, 2023Jun 6, 2023Certified, then withdrawn
$86,000–$106,000
Level II		New York, NYApr 19, 2023Jul 17, 2023Certified
$86,000–$90,000
Level II		New York, NYMar 3, 2023May 1, 2023Certified

Other jobs at Memorial Sloan Kettering Cancer Center

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).